Clinical Trials Directory

Trials / Unknown

UnknownNCT01742689

Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic

Assessment of Analgesic Efficacy of Intranasal Desmopressin in the Treatment of Acute Pain in Patients With Renal Colic

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
88 (estimated)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
All
Age
15 Years – 65 Years
Healthy volunteers
Not accepted

Summary

In this study we will compare pain intensity and side effects at different time points after the intranasal administration of desmopressin or placebo in patients with acute renal colic pain.

Detailed description

Obstruction of the urinary tract can increase pelvi-ureteric pressure and thus cause renal colic pain, which can be very severe. Conventional therapy consists of non-steroidal anti-inflammatory drugs (NSAIDs) and opioids. NSAIDs have many side effects and opioids are not always available. In addition, the intravenous form of NSAIDs is not routinely available in Iran, and the drug is mainly used in the form of suppository. Due to these reasons, research on newer replacement therapies with fewer side effects is necessary. Desmopressin intranasal spray has already been shown to be partially effective in renal colic pain in a few studies. Due to its lower side effects, we decided to conduct a clinical trial with desmopressin to evaluate pain relief in renal colic. In this study, eighty-eight patients with acute renal colic pain, referring to Imam Khomeini Hospital in Tehran, will be randomly allocated to receive either intranasal desmopressin or placebo. Both groups will also receive 100 milligram indomethacin suppository. Pain intensity will be assessed and recorded using a verbal numeric rating scale, before nasal spray, and in minutes 5, 10, 15, 30, 45 and 60 after receiving the allocated treatment. Possible side effects will also be asked and recorded. The patient and the investigator responsible for recording pain intensity will not be aware of the administered drug. The results will be compared before and after treatment in each group, using appropriate statistical tests.

Conditions

Interventions

TypeNameDescription
DRUGDesmopressin intranasal spray10 microgram per puff, 40 microgram is Descript
DRUGPlacebo intranasal spraySaline spray identical to desmopressin, administered as 4 sprays
DRUGIndomethacin suppositoryIndomethacin suppository 100 milligram single dose

Timeline

Start date
2012-03-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2012-12-05
Last updated
2012-12-05

Locations

2 sites across 1 country: Iran

Source: ClinicalTrials.gov record NCT01742689. Inclusion in this directory is not an endorsement.